C390-0189 Screening compound: 4-[3-(4-methylphenyl)-6-oxo-4-phenyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-5-yl]benzoic acid

C390-0189 Screening compound: 4-[3-(4-methylphenyl)-6-oxo-4-phenyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-5-yl]benzoic acid
C390-0189 Screening compound: 4-[3-(4-methylphenyl)-6-oxo-4-phenyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-5-yl]benzoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound C390-0189
4-[3-(4-methylphenyl)-6-oxo-4-phenyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-5-yl]benzoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C390-0189

Molecular Formula

C25H19N3O3 (C25 H19 N3 O3)

Compound Name

4-[3-(4-methylphenyl)-6-oxo-4-phenyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-5-yl]benzoic acid

IUPAC name

4-[3-(4-methylphenyl)-6-oxo-4-phenyl-1H4H5H6H-pyrrolo[34-c]pyrazol-5-yl]benzoic acid

SMILES

Cc(cc1)ccc1-c1n[nH]c(C2=O)c1C(c1ccccc1)N2c(cc1)ccc1C(O)=O

InChI

InChI=1S/C25H19N3O3/c1-15-7-9-16(10-8-15)21-20-22(27-26-21)24(29)28(23(20)17-5-3-2-4-6-17)19-13-11-18(12-14-19)25(30)31/h2-14,23H,1H3,(H,26,27)(H,30,31)/t23-/m0/s1

InChI Key

UADHLQCUBKDLGB-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD06196030

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

409.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.963

Distribution Coefficient, logD

2.568

Water Solubility, LogSw

-4.42

Polar Surface Area

67.935

Acid Dissociation Constant (pKa)

5.01

Base Dissociation Constant (pKb)

-3.77

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

8.00

C390-0189 in Drug Discovery

Included in Screening Libraries

RAR (Nuclear receptors) Ligands Library (6524 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Cancer
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with C390-0189 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C390-0189?
Check Price and Availability of C390-0189, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C390-0189 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C390-0189
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C390-0189
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C390-0189 available by request